KAIST Develops AI That Automatically Designs Optimal Drug Candidates for Cancer-Targeting Mutations​ (IMAGE)

The Korea Advanced Institute of Science and Technology (KAIST)

KAIST Develops AI That Automatically Designs Optimal Drug Candidates for Cancer-Targeting Mutations​

Caption

< (From left) Ph.D candidate Wonho Zhung, Ph.D cadidate Joongwon Lee , Prof. Woo Young Kim , Ph.D candidate Jisu Seo >

Credit

KAIST

Usage Restrictions

NO

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.